December2 , 2023

Historic Collaborative Effort: Pharma Giants Rethink the Future of Life Sciences Transacting at MediLedger Face-to-Face Meeting, Hosted by Cencora


Edobles Launches Revolutionary Mood-Enhancing Edibles

Miami-Based Company, Edobles, Launches Mood-Enhancing Edibles Expertly Crafted With Natural Ingredient Blends to Boost Customers’ Moods One Bite at a Time

Edobles Launches Revolutionary Mood-Enhancing Edibles
Ed?bles Launches Revolutionary Mood-Enhancing Edibles

Miami-based company, Ed?bles, launches mood-enhancing edibles expertly crafted with natural ingredient blends to boost customers' moods one bite at a time.

Edobles (Edobles, LLC), a new player in the infused edibles industry, has opened its doors and launched its line of products designed to enhance mood. With a focus on catering to various moods, Edobles offers a range of options to boost euphoria, increase energy levels, promote calmness and balance, and induce restful sleep.

“We’re a mood-based company first and foremost,” says Miguel Cruz, Creative Director for the brand, “Our goal is to create a product that’s easy to consume, whether at home or on the go, that’s effective at enhancing or creating a desired mood in one bite.”

In a market saturated with infused edibles, Edobles stands out by providing mood-boosting edibles that are backed by scientific research. Each product is carefully formulated with specific ingredients known for their mood-enhancing properties.

Edobles takes pride in the quality and purity of its products. All items undergo rigorous third-party lab testing to ensure accuracy, safety, and purity. These independent lab tests provide unbiased findings, giving consumers peace of mind when incorporating Edobles products into their daily routines.

The launch of Edobles marks the first-ever company focused solely on mood-enhancement solutions. While there are several infused edibles brands on the market, Edobles is the first to specifically cater to different moods. The range of products, including Energy, Euphoria, and Sleep Edibles, as well as Libido Gummies and more, ensures that individuals can find the perfect option to suit their desired mood.

By prioritizing the quality, safety, and effectiveness of their offerings, Edobles aims to empower individuals to take control of their mood and enhance their overall daily routines. With the launch of its innovative products, Edobles is set to revolutionize the way we approach mood enhancement and well-being.

About Edobles

Edobles is an edible supplements company focused on the science of mood enhancement through the power of all-natural ingredient blends. With mood-enhancing products ranging from providing better sleep and more energy to mental focus and bodily relaxation, we’re committed to giving our customers an all-natural way to enhance any mood or feeling in a new and delicious way. To learn more, please visit or contact us at [email protected].

Contact Information:
Carla Centurion
Company Affairs Liaison
[email protected]

Original Source: Edobles Launches Revolutionary Mood-Enhancing Edibles
gossip news
free fashion tv


In what promises to be a pivotal moment for the pharmaceutical industry, major stakeholders convened last week for the MediLedger Face-to-Face Meeting from October 24-25, 2023, at Cencora’s headquarters (formerly AmerisourceBergen). This collaborative gathering paves the way for a transformed healthcare supply chain, characterized by efficiency, transparency, and innovation.

Distinguished Participants Include:

Kyowa Kirin, Cipla, Abbvie, Amneal Pharmaceuticals, Cardinal Health, AstraZeneca, Grifols, Kedrion Biopharma, The Resource Group, Vizient Inc, Viatris, Novadoz Pharmaceuticals, Amici Pharmaceuticals, Armas Pharmaceuticals, Ferring Pharmaceuticals, Bristol Myers Squibb, Takeda Pharmaceuticals, Novo Nordisk, Health Industry Business Communications Council, Endo International, Pfizer, Premier Inc., Curascript SD, GSK, Genentech, Cencora, and Hikma Pharmaceuticals.

Key Topics of Discussion Include:

  • Financial Impact: A deep dive into the ROI of MediLedger and its implications for the bottom line, including reduction of unnecessary write-offs, preventing rebills, reducing administrative waste, and improving top-line revenue
  • Data Alignment: A focus on inter-industry data alignment, cleanup, and the end-to-end process from distributors to GPO customers to manufacturers to health systems, ensuring seamless backend customer mapping.
  • Demystifying Claims: A comprehensive walkthrough of the improved claims process on the network, its workflow, and integration points, promoting a standardized aligned approach for all participants.
  • Driving Scalability: Exploring strategies to escalate from a single contract to an all-encompassing model on the network, with insights from Grifols on their transition experience.
  • Business Intelligence Capabilities: An introduction to new BI capabilities including the creation of flexible analytics and reports.
  • Artificial Intelligence Integration: Using AI in data alignment to map all stakeholders to relevant information.
  • Fostering Network Adoption: Strategies to eliminate network adoption barriers, simplify implementations, align protocols, and encourage broader stakeholder involvement.

Mike Connelly, VP, Pricing & Contract Management at Cencora, commented, “This meeting is an important step as we translate discussions into actionable strategies in order to directly benefit providers, patients and streamline our processes.”

As the industry behemoths gathered to redefine the landscape, the global healthcare community watched with anticipation for transformative outcomes.

To learn more about MediLedger, click here.

About MediLedger:

MediLedger, administered by Chronicled, is an industry pioneer, offering blockchain-based solutions for the healthcare industry. Their decentralized network enables seamless, transparent communication among healthcare providers, enhancing patient safety, improving healthcare outcomes, and optimizing operations. Learn more here.

Contact Information:
Juli Cooper
Head of Marketing
[email protected]

Original Source: Historic Collaborative Effort: Pharma Giants Rethink the Future of Life Sciences Transacting at MediLedger Face-to-Face Meeting, Hosted by Cencora